{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:42:30Z","timestamp":1760708550697},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T00:00:00Z","timestamp":1365984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2369-14-85","type":"journal-article","created":{"date-parts":[[2013,4,15]],"date-time":"2013-04-15T20:14:10Z","timestamp":1366056850000},"source":"Crossref","is-referenced-by-count":31,"title":["Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)"],"prefix":"10.1186","volume":"14","author":[{"given":"Per-Anton","family":"Westerberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5sa","family":"Tivesten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magnus K","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Mellstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Orwoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claes","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias E","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torbj\u00f6rn","family":"Linde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6sten","family":"Ljunggren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,15]]},"reference":[{"issue":"7","key":"515_CR1","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1681\/ASN.2005010052","volume":"16","author":"O Gutierrez","year":"2005","unstructured":"Gutierrez O, Isakova T, Rhee E, Shah A, Holmes J, Collerone G, Juppner H, Wolf M: Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease. J Am Soc Nephrol. 2005, 16 (7): 2205-2215. 10.1681\/ASN.2005010052.","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"515_CR2","doi-asserted-by":"publisher","first-page":"3202","DOI":"10.1093\/ndt\/gfm347","volume":"22","author":"PA Westerberg","year":"2007","unstructured":"Westerberg PA, Linde T, Wikstrom B, Ljunggren O, Stridsberg M, Larsson TE: Regulation of fibroblast growth factor-23 in chronic kidney disease. Nephrol Dial Transplant. 2007, 22 (11): 3202-3207. 10.1093\/ndt\/gfm347.","journal-title":"Nephrol Dial Transplant"},{"issue":"9731","key":"515_CR3","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","volume":"375","author":"K Matsushita","year":"2010","unstructured":"Matsushita K, van der Velde M, Astor BC, Woodward M, Levey AS, de Jong PE, Coresh J, Gansevoort RT: Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet. 2010, 375 (9731): 2073-2081.","journal-title":"Lancet"},{"issue":"17","key":"515_CR4","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","volume":"112","author":"M Tonelli","year":"2005","unstructured":"Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G: Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation. 2005, 112 (17): 2627-2633. 10.1161\/CIRCULATIONAHA.105.553198.","journal-title":"Circulation"},{"issue":"21","key":"515_CR5","doi-asserted-by":"publisher","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","volume":"119","author":"E Hagstrom","year":"2009","unstructured":"Hagstrom E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundstrom J, Melhus H, Held C, Lind L, Michaelsson K, et al: Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation. 2009, 119 (21): 2765-2771. 10.1161\/CIRCULATIONAHA.108.808733.","journal-title":"Circulation"},{"issue":"23","key":"515_CR6","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1001\/jama.2011.826","volume":"305","author":"T Isakova","year":"2011","unstructured":"Isakova T, Xie H, Yang W, Xie D, Anderson AH, Scialla J, Wahl P, Gutierrez OM, Steigerwalt S, He J, et al: Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011, 305 (23): 2432-2439. 10.1001\/jama.2011.826.","journal-title":"JAMA"},{"issue":"2","key":"515_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.atherosclerosis.2009.05.013","volume":"207","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE: Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis. 2009, 207 (2): 546-551. 10.1016\/j.atherosclerosis.2009.05.013.","journal-title":"Atherosclerosis"},{"issue":"19","key":"515_CR8","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.108.844506","volume":"119","author":"OM Gutierrez","year":"2009","unstructured":"Gutierrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, et al: Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009, 119 (19): 2545-2552. 10.1161\/CIRCULATIONAHA.108.844506.","journal-title":"Circulation"},{"issue":"10","key":"515_CR9","doi-asserted-by":"publisher","first-page":"3125","DOI":"10.1093\/ndt\/gfp205","volume":"24","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Hansen T, Johansson L, Ahlstrom H, Larsson A, Lind L, Larsson TE: Relationship between circulating FGF23 and total body atherosclerosis in the community. Nephrol Dial Transplant. 2009, 24 (10): 3125-3131. 10.1093\/ndt\/gfp205.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"515_CR10","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","volume":"205","author":"MA Mirza","year":"2009","unstructured":"Mirza MA, Larsson A, Lind L, Larsson TE: Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community. Atherosclerosis. 2009, 205 (2): 385-390. 10.1016\/j.atherosclerosis.2009.01.001.","journal-title":"Atherosclerosis"},{"issue":"10","key":"515_CR11","doi-asserted-by":"publisher","first-page":"640","DOI":"10.7326\/0003-4819-152-10-201005180-00004","volume":"152","author":"BD Parker","year":"2010","unstructured":"Parker BD, Schurgers LJ, Brandenburg VM, Christenson RH, Vermeer C, Ketteler M, Shlipak MG, Whooley MA, Ix JH: The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the heart and soul study. Ann Intern Med. 2010, 152 (10): 640-648. 10.7326\/0003-4819-152-10-201005180-00004.","journal-title":"Ann Intern Med"},{"issue":"4","key":"515_CR12","doi-asserted-by":"publisher","first-page":"841","DOI":"10.3945\/ajcn.2010.29749","volume":"92","author":"K Michaelsson","year":"2010","unstructured":"Michaelsson K, Baron JA, Snellman G, Gedeborg R, Byberg L, Sundstrom J, Berglund L, Arnlov J, Hellman P, Blomhoff R, et al: Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010, 92 (4): 841-848. 10.3945\/ajcn.2010.29749.","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"515_CR13","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1093\/aje\/kwp227","volume":"170","author":"A Kilkkinen","year":"2009","unstructured":"Kilkkinen A, Knekt P, Aro A, Rissanen H, Marniemi J, Heliovaara M, Impivaara O, Reunanen A: Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009, 170 (8): 1032-1039. 10.1093\/aje\/kwp227.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"515_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/ejcn.2009.140","volume":"64","author":"RD Semba","year":"2010","unstructured":"Semba RD, Houston DK, Bandinelli S, Sun K, Cherubini A, Cappola AR, Guralnik JM, Ferrucci L: Relationship of 25-hydroxyvitamin D with all-cause and cardiovascular disease mortality in older community-dwelling adults. Eur J Clin Nutr. 2010, 64 (2): 203-209. 10.1038\/ejcn.2009.140.","journal-title":"Eur J Clin Nutr"},{"issue":"5","key":"515_CR15","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/00365510601187773","volume":"67","author":"M Flodin","year":"2007","unstructured":"Flodin M, Jonsson AS, Hansson LO, Danielsson LA, Larsson A: Evaluation of gentian cystatin C reagent on abbott Ci8200 and calculation of glomerular filtration rate expressed in mL\/min\/1.73\u2009m(2) from the cystatin C values in mg\/L. Scand J Clin Lab Invest. 2007, 67 (5): 560-567. 10.1080\/00365510601187773.","journal-title":"Scand J Clin Lab Invest"},{"issue":"6","key":"515_CR16","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1056\/NEJMoa0706130","volume":"359","author":"OM Gutierrez","year":"2008","unstructured":"Gutierrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Juppner H, et al: Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008, 359 (6): 584-592. 10.1056\/NEJMoa0706130.","journal-title":"N Engl J Med"},{"issue":"10","key":"515_CR17","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1681\/ASN.2010121224","volume":"22","author":"J Kendrick","year":"2011","unstructured":"Kendrick J, Cheung AK, Kaufman JS, Greene T, Roberts WL, Smits G, Chonchol M: FGF-23 associates with death, cardiovascular events, and initiation of chronic dialysis. J Am Soc Nephrol. 2011, 22 (10): 1913-1922. 10.1681\/ASN.2010121224.","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"515_CR18","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1093\/ndt\/gfq309","volume":"25","author":"S Seiler","year":"2010","unstructured":"Seiler S, Reichart B, Roth D, Seibert E, Fliser D, Heine GH: FGF-23 and future cardiovascular events in patients with chronic kidney disease before initiation of dialysis treatment. Nephrol Dial Transplant. 2010, 25 (12): 3983-3989. 10.1093\/ndt\/gfq309.","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"515_CR19","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ahj.2011.02.012","volume":"161","author":"EN Taylor","year":"2011","unstructured":"Taylor EN, Rimm EB, Stampfer MJ, Curhan GC: Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J. 2011, 161 (5): 956-962. 10.1016\/j.ahj.2011.02.012.","journal-title":"Am Heart J"},{"issue":"3","key":"515_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","volume":"60","author":"JH Ix","year":"2012","unstructured":"Ix JH, Katz R, Kestenbaum BR, de Boer IH, Chonchol M, Mukamal KJ, Rifkin D, Siscovick DS, Sarnak MJ, Shlipak MG: Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (cardiovascular health study). J Am Coll Cardiol. 2012, 60 (3): 200-207. 10.1016\/j.jacc.2012.03.040.","journal-title":"J Am Coll Cardiol"},{"key":"515_CR21","volume-title":"Kidney Int","author":"J Arnlov","year":"2012","unstructured":"Arnlov J, Carlsson AC, Sundstrom J, Ingelsson E, Larsson A, Lind L, Larsson TE: Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community. Kidney Int. 2012"},{"issue":"3","key":"515_CR22","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s00198-011-1809-5","volume":"23","author":"H Johansson","year":"2012","unstructured":"Johansson H, Oden A, Kanis J, McCloskey E, Lorentzon M, Ljunggren O, Karlsson MK, Thorsby PM, Tivesten A, Barrett-Connor E, et al: Low serum vitamin D is associated with increased mortality in elderly men: MrOS sweden. Osteoporos Int. 2012, 23 (3): 991-999. 10.1007\/s00198-011-1809-5.","journal-title":"Osteoporos Int"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2369-14-85\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2369-14-85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T03:57:31Z","timestamp":1548215851000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/1471-2369-14-85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["515"],"URL":"https:\/\/doi.org\/10.1186\/1471-2369-14-85","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,15]]},"article-number":"85"}}